Log in
Enquire now
‌

Avidicure

Developer of a multifunctional antibody modality to treat cancer.

OverviewStructured DataIssuesContributors

Contents

avidicure.com
Is a
Organization
Organization
Company
Company

Company attributes

Industry
Health technology
Health technology
Biotechnology
Biotechnology
Location
Leiden
Leiden
CEO
‌
Arthur Lahr
Founder
‌
Robert Friesen
‌
Arthur Lahr
‌
Govert Schouten
Number of Employees (Ranges)
11 – 50
Email Address
info@avidicure.com
Investors
BioGeneration Ventures
BioGeneration Ventures
Kurma Partners
Kurma Partners
Brabantse Ontwikkelings Maatschappij (BOM)
Brabantse Ontwikkelings Maatschappij (BOM)
V-Bio Ventures
V-Bio Ventures
‌
Curie Capital
EQT Life Sciences
EQT Life Sciences
Founded Date
2022
Total Funding Amount (USD)
50,000,000
Latest Funding Round Date
April 24, 2025
Latest Funding Type
Seed
Seed
COO
‌
Dirk De Naeyer
Country
Netherlands
Netherlands

Other attributes

Latest Funding Round Amount (USD)
50,000,000
No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more companies like Avidicure

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.